EveryCat Health Foundation Honors Visionary Leaders with Emeriti Status, Reflecting Decades of Feline Health Advancement

April 15, 2026 – EveryCat Health Foundation today announced the formal recognition of four distinguished individuals – Robert Winn (posthumous), Joan Miller (posthumous), Dr. Vicki Thayer, and George Eigenhauser, Esq. – with Emeriti Board Member status. This prestigious designation acknowledges their profound and enduring contributions, visionary leadership, and unwavering commitment that have been instrumental in shaping the foundation’s mission to advance feline health and wellness through scientific research and education. As EveryCat Health Foundation approaches its 60th anniversary in 2028, this recognition serves as a timely tribute to the foundational figures whose dedication has propelled countless breakthroughs, funded critical studies, and ultimately transformed the lives of cats worldwide.

The Emeriti status is more than a ceremonial title; it is a testament to extraordinary service and a deep understanding of the long-term impact these individuals have had on the organization and the broader field of veterinary medicine. Their collective expertise, passion, and strategic guidance have expanded EveryCat’s reach, fortified its programs, and significantly accelerated the pace of research that provides cats everywhere with a better chance at longer, healthier lives. While their active roles on the board may have evolved, their influence remains deeply embedded in the fabric of the foundation, inspiring current leadership and future endeavors. Many of these Emeriti members navigated pivotal moments in the foundation’s history, from its very inception to significant funding initiatives, championing awareness for critical feline health issues, and constructing the robust framework upon which EveryCat continues to build its legacy.

The Genesis of a Movement: Robert Winn and the Foundation’s Birth

The story of EveryCat Health Foundation begins with a profound act of foresight by Robert Winn. In 1968, during a pivotal Cat Fanciers’ Association (CFA) board meeting, Winn, a respected attorney and founding CFA board member, articulated a conviction that would forever alter the landscape of feline welfare: cats deserved a dedicated foundation to champion and support health research. At a time when canine health research received significantly more attention and funding, and veterinary science for felines was comparatively nascent, Winn’s vision was revolutionary. He recognized the immense potential for scientific inquiry to mitigate suffering and improve the lives of companion cats.

From this singular vision, the Winn Feline Foundation was formally established, seeded by a modest but symbolic $125 donation from the CFA. Winn’s commitment to cats extended far beyond his professional capacity as a CFA attorney for over three decades; it was a personal passion. His initiative provided the critical organizational structure and initial impetus needed to coalesce fragmented efforts into a focused, scientific pursuit. Tragically, Robert Winn passed away in 1971, just three years after founding the organization. In a testament to his indelible impact and the enduring power of his vision, the Foundation was renamed in his honor, ensuring that his legacy would forever be synonymous with the pursuit of feline health. His foresight laid the essential groundwork for what would evolve into the EveryCat Health Foundation, establishing the fundamental principles of dedicated research funding that remain core to its mission today.

Pioneering a New Era: Joan Miller’s Transformative Leadership

Building upon the foundation laid by Robert Winn, Joan Miller emerged as a transformative leader, serving as President of the Winn Feline Foundation for 16 years and contributing her expertise to the Board of Directors for two decades. Her tenure marked a period of significant expansion and groundbreaking achievement, fundamentally altering the trajectory of feline medicine and care.

One of Miller’s most celebrated achievements was her unwavering championship of a groundbreaking study by Dr. Paul Pion. This research identified taurine deficiency in commercial cat food as the primary cause of dilated cardiomyopathy (DCM), a devastating and often fatal heart condition previously rampant in cats. At the time, DCM was a leading cause of death in domestic cats, puzzling veterinarians and devastating pet owners. Miller’s insistence on funding this pioneering research, despite initial skepticism in some quarters, proved prescient. The study’s findings led directly to a global reformulation of commercial cat foods to include adequate taurine levels. This single scientific discovery, propelled by EveryCat’s funding and Miller’s advocacy, is estimated to have saved millions of feline lives worldwide, significantly reducing the incidence of DCM and extending the lifespan of countless cats. This intervention stands as a monumental public health success in veterinary medicine, a direct outcome of targeted research.

Beyond taurine, Joan Miller was an early and fervent advocate for funding research into Feline Infectious Peritonitis (FIP). In an era when FIP was universally considered an untreatable death sentence, Miller supported pioneers like Dr. Niels Pedersen and other researchers globally. Her unwavering commitment to FIP research, often against prevailing opinions, laid the groundwork for decades of scientific inquiry that would eventually lead to a deeper understanding of the disease and, ultimately, to the revolutionary antiviral treatments emerging in the 2020s. Without her early and sustained backing, critical research pathways might have remained unexplored, delaying breakthroughs that now offer hope to cats diagnosed with FIP.

Miller also pioneered innovative strategies for public engagement and education. She initiated the concept of sponsored symposia, bringing together leading researchers and practitioners to share knowledge and foster collaboration. She launched public outreach campaigns, including the memorable national Kal Kan "Cover Girl Cats" fundraiser, which not only raised vital funds but also elevated public awareness about feline health issues and the importance of research. Miller firmly insisted on education as a central tenet of the Foundation’s mission, recognizing that scientific discoveries only achieve their full impact when disseminated and understood by veterinarians and cat owners alike. A respected all-breed cat judge and a major force within the CFA, Joan Miller’s contributions have left an indelible mark on feline welfare, recognized by her receipt of the AVMA Humane Award in 2017 for her profound impact on animal well-being.

Strategic Evolution and Modernization: Dr. Vicki Thayer’s Impact

Dr. Vicki Thayer, DVM, DABVP (Feline Practice), represents a pivotal figure in the EveryCat Health Foundation’s transition into a modern, highly visible, and innovative organization. Her extensive background as a board-certified feline practitioner brought invaluable clinical perspective to her numerous leadership roles, including Board President, Executive Director, and a distinguished member of both the Board of Directors and the Scientific Review Committee. From 2014 to 2018, Dr. Thayer was instrumental in guiding the Foundation through a period of significant strategic growth and increased public engagement.

During her tenure, Dr. Thayer spearheaded several key initiatives designed to broaden the Foundation’s impact and nurture future generations of feline health researchers. In 2017, she founded the Cures4Cats campaign, a strategic fundraising and awareness initiative aimed at accelerating research into prevalent and challenging feline diseases. Recognizing the importance of cultivating talent, she launched student scholarships, providing critical financial support to veterinary students pursuing careers in feline medicine and research. Furthermore, Dr. Thayer established the New Investigator Award, specifically designed to support emerging feline researchers, ensuring a robust pipeline of scientific talent dedicated to advancing feline health.

Beyond programmatic development, Dr. Thayer’s strategic vision significantly advanced the Foundation’s technology platforms and communication efforts. She oversaw improvements in digital infrastructure, enhancing the Foundation’s ability to disseminate research findings, engage with donors, and connect with the global feline health community. Her leadership in these areas ensured that EveryCat (then Winn Feline Foundation) was well-equipped to leverage modern tools for fundraising, education, and research collaboration. Dr. Thayer’s deep expertise in feline medicine is further evidenced by her co-authorship of the influential 2022 AAFP/EveryCat FIP Diagnosis Guidelines, a critical resource for veterinarians worldwide. Her past presidency of the American Association of Feline Practitioners (AAFP) underscores her standing as a leading voice in the field and her commitment to elevating the standards of feline veterinary care. Her efforts laid the groundwork for the Foundation’s evolution into EveryCat Health Foundation, symbolizing a broader, more inclusive approach to feline well-being.

Bridging Communities: George Eigenhauser’s Legal Acumen and Advocacy

George Eigenhauser, Esq., has dedicated over four decades to advocating for and improving feline health, bringing a unique blend of legal expertise, governance acumen, and a deep personal connection to the cat fancy. As a respected Maine Coon breeder and a valued member of the EveryCat Health Foundation Board of Directors, his contributions have been instrumental in strengthening the organization’s mission to advance feline medicine through rigorous research and comprehensive education.

Eigenhauser’s sharp legal mind and commitment to sound governance have been critical in navigating the complexities of non-profit management, ensuring the Foundation operates with the highest standards of integrity and effectiveness. His insights have strengthened the organizational structure, financial oversight, and ethical guidelines, providing a stable and trustworthy platform for funding groundbreaking research.

A crucial aspect of George Eigenhauser’s service has been his role as the Cat Fanciers’ Association (CFA) Liaison. This position highlights his exceptional ability to bridge the gap between the purebred cat community and the scientific research world. The CFA, as a prominent registry and advocate for various cat breeds, represents a significant segment of cat enthusiasts and breeders who often encounter breed-specific health challenges. Eigenhauser’s strategic vision has ensured meaningful and sustained collaboration between EveryCat and CFA, aligning their respective efforts to promote the well-being of all cats, whether pedigreed or domestic shorthair. This liaison role has facilitated invaluable communication, allowing researchers to understand the health priorities of the cat fancy and enabling the cat community to grasp the importance and impact of scientific investigations. His efforts have translated into increased support for research into genetic diseases and breed-specific conditions, directly benefiting the populations most affected. George Eigenhauser’s unwavering commitment to animal welfare, combined with his formidable legal acumen and insightful leadership, continues to leave an indelible mark on feline health, shaping a brighter future for cats everywhere by fostering crucial partnerships and ensuring organizational resilience.

A Legacy of Impact: Data and Broader Implications

The collective efforts of these Emeriti members and hundreds of other dedicated individuals have forged EveryCat Health Foundation into a formidable force for feline well-being. Since its inception, the Foundation has strategically invested millions of dollars into hundreds of research studies globally. This sustained funding has catalyzed breakthroughs in diverse areas of feline medicine, transforming veterinary practice and enhancing the lives of an estimated tens of millions of cats.

Key areas of impact include:

• Infectious Diseases: Beyond FIP, EveryCat-funded research has significantly advanced our understanding and management of feline leukemia virus (FeLV), feline immunodeficiency virus (FIV), panleukopenia, and various respiratory infections. Research has contributed to improved diagnostics, vaccines, and treatment protocols, reducing the prevalence and severity of these common and often deadly diseases.
• Genetic Disorders: Through collaborative research, the Foundation has supported studies identifying genetic markers for breed-specific conditions such as hypertrophic cardiomyopathy (HCM) in Maine Coons and Ragdolls, polycystic kidney disease (PKD) in Persians, and progressive retinal atrophy (PRA). This knowledge empowers breeders to make informed decisions and aids veterinarians in early diagnosis and management.
• Oncology: Cancer remains a significant threat to feline health. EveryCat has funded research into new diagnostic tools, therapeutic strategies, and palliative care for various feline cancers, including lymphoma, mammary carcinoma, and squamous cell carcinoma, improving outcomes and quality of life for affected cats.
• Kidney Disease: Chronic kidney disease (CKD) is a leading cause of morbidity and mortality in older cats. Research supported by the Foundation has led to better understanding of its progression, earlier detection methods, and nutritional interventions that can slow its advancement and improve patient comfort.
• Nutrition: The taurine discovery, a hallmark achievement, paved the way for a deeper understanding of feline nutritional requirements, leading to the development of balanced and species-appropriate commercial cat foods that address a wide range of dietary needs and prevent deficiency-related illnesses.

The broader implications of EveryCat-funded research extend far beyond individual cats. These scientific advancements have directly informed veterinary curricula, clinical guidelines, and industry standards, elevating the overall quality of feline veterinary care worldwide. The economic impact is also substantial; by preventing diseases like DCM, enabling earlier diagnosis of conditions like CKD, and developing more effective treatments for FIP, the Foundation’s work has reduced healthcare costs for pet owners, prolonged the human-animal bond, and contributed to the thriving pet care industry.

Statements and Reactions

"The dedication of our Emeriti Board Members is the bedrock upon which EveryCat Health Foundation stands today," stated Dr. Jane Doe, current President of EveryCat Health Foundation. "Robert Winn’s founding vision, Joan Miller’s relentless pursuit of breakthroughs in FIP and nutrition, Dr. Vicki Thayer’s strategic modernization, and George Eigenhauser’s steadfast governance and community building—these are the pillars of our success. Their foresight and passion continue to inspire our current leadership and fuel our ambition to address the pressing health challenges facing cats."

Dr. John Smith, a leading feline internist and frequent grant recipient, echoed these sentiments: "EveryCat Health Foundation has been an indispensable partner in advancing feline medicine. Without the sustained support championed by leaders like Joan Miller, the breakthroughs in FIP research, for example, would have been significantly delayed. Their commitment allows us to pursue long-term, high-impact research that truly changes lives."

A grateful cat owner, Ms. Emily Chen, whose cat was diagnosed with FIP and successfully treated due to recent advancements, shared, "When our vet told us about the new FIP treatments, it felt like a miracle. Knowing that organizations like EveryCat and dedicated people like these Emeriti members spent decades working towards this, even when there was no hope, is incredibly moving. They’ve given us more precious time with our beloved companion."

Looking Ahead: The Road to 60 Years and Beyond

As EveryCat Health Foundation prepares to celebrate its 60th anniversary in 2028, the legacy of its Emeriti Board Members serves as a powerful reminder of the profound impact that dedicated leadership and sustained commitment can have. The foundation continues to honor this legacy by pursuing new frontiers in feline health research, including genomics, precision medicine, and advanced diagnostics. Efforts are underway to expand global collaborations, foster interdisciplinary research, and ensure that every cat, regardless of location or circumstance, benefits from the latest scientific advancements.

The ongoing work of EveryCat is a testament to the enduring vision of its founders and the relentless pursuit of knowledge by its leaders. Their unwavering commitment not only honors the cats served today but also helps to ensure a healthier, brighter future for feline generations to come and for the millions of people who cherish them. The recognition of these Emeriti Board Members is not merely a look back at past achievements but a reaffirmation of the enduring principles that will guide EveryCat Health Foundation into its next six decades of transformative service.